Get the Stockscreener App
3.38
5.30%
0.17
After Hours:
3.25
-0.13
-3.85%
Creative Medical Technology Holdings Inc Stock (CELZ) Latest News
Clinical Trials News Live Feed - StockTitan
Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain - The Manila Times
Revolutionary Stem Cell Therapy Tackles Chronic Back Pain: First Trial Results Unveiled - StockTitan
Equinix, Inc. (Nasdaq: EQIX) Investor Alert: Grabar Law Investigates Claims as Securities Fraud Class Action - EIN News
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update - EIN News
Degenerative Disc Disease Treatment Market Size in the 7MM was - openPR
CELZ (Creative Medical Technology Holdings) 3-Year Revenue Growth Rate : -87.20% (As of Sep. 2024) - GuruFocus.com
Bunion correction systems Market Key Players AnalysisStryker - openPR
Creative Global Technology Holdings Ltd's Quiet Period Set To End on January 6th (NASDAQ:CGTL) - MarketBeat
Orange County Bancorp Announces Two-for-One Stock Split - Defense World
Optical Cable Corporation Releases Fourth Quarter and Fiscal Year 2024 Financial Results - Defense World
TechPrecision Corporation Announces Corporate Changes Following Annual Meeting - Defense World
Versus Systems Completes Corporate Continuance and Securities Issuance - Defense World
Creative Medical Technology Holdings, Inc. Reports Amendment to Articles of Incorporation and Voting Results Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) filed a Form 8-K with the Securities and Exchange Commission on December 19, 20 - Defense World
Mergers & Acquisitions Tracker - Plastics News
CELZ stock touches 52-week low at $2.11 amid market challenges - Investing.com India
Creative Global Technology Holdings Ltd trading resumes - Nasdaq
CELZ stock touches 52-week low at $2.21 amid market challenges - Investing.com Australia
CELZ stock touches 52-week low at $2.36 amid market challenges By Investing.com - Investing.com South Africa
CELZ stock touches 52-week low at $2.36 amid market challenges - Investing.com Canada
CELZ (Creative Medical Technology Holdings) 9-Day RSI : 39.05 (As of Nov. 28, 2024) - GuruFocus.com
Creative Global Tech opens at $4.29, IPO priced at $4 per share - Yahoo Finance
Creative Global Technology Holdings Limited Announces Closings of Its Initial Public Offering and the Underwriter’s Over-Allotment Option - Yahoo Finance
Degenerative Disc Disease Market Size in the 7MM was ~USD 3,600 Million in 2023, estimated DelveInsight - openPR
Creative Global Technology Holdings Limited Announces Pricing of Its Initial Public Offering - Yahoo Finance
CELZ (Creative Medical Technology Holdings) 3-Year FCF Grow - GuruFocus.com
CELZ (Creative Medical Technology Holdings) Cash, Cash Equi - GuruFocus.com
CELZ (Creative Medical Technology Holdings) Total Inventories : $0.00 Mil (As of Sep. 2024) - GuruFocus.com
CELZ stock touches 52-week low at $2.49 amid market challenges - Investing.com Australia
CELZ stock touches 52-week low at $2.49 amid market challenges By Investing.com - Investing.com South Africa
Can Creative Global Technology Holdings Limited's (NASDAQ:CGTL) ROE Continue To Surpass The Industry Average? - Yahoo Finance
Equities Analysts Issue Forecasts for CELZ FY2024 Earnings - Defense World
Novozymes A/S (OTCMKTS:NVZMY) & Creative Medical Technology (NASDAQ:CELZ) Head-To-Head Comparison - Defense World
Q1 Earnings Estimate for CELZ Issued By Roth Capital - Defense World
Creative Medical Technology files to sell 0.83M shares of common stocks by selling shareholders - MSN
Creative Technology (SGX:C76) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Mesa medical manufacturer BioLab Holdings Inc. hires new COO - Daily Independent
Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent - EIN News
Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment - The Manila Times
Electrify Expo Expands to New Markets in 2025 as Dallas and Chicago Join the Nation's Largest EV Festival - The Manila Times
Creative Medical passes safety review for back pain trial By Investing.com - Investing.com UK
Creative Medical Tech's CELZ-201 Back Pain Trial Advances After Positive Safety Review | CELZ Stock News - StockTitan
Creative Planning Lowers Holdings in Mirion Technologies, Inc. (NYSE:MIR) - Defense World
Weekly TechBio News: ADMET Prediction - substack.com
Creative Planning Buys New Stake in GigaCloud Technology Inc. (NASDAQ:GCT) - Defense World
Creative Medical Technology Holdings Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.02 loss in 3Q 2023) - Yahoo Finance UK
Creative Planning Purchases 22,171 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) - Defense World
Creative Planning Has $334,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Creative Medical Technology Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Creative Medical Technology Holdings Inc. (CELZ) Quarterly 10-Q Report - Quartzy
CELZ stock touches 52-week low at $2.65 amid market challenges - Investing.com Australia
Creative Planning Takes Position in Credo Technology Group Holding Ltd (NASDAQ:CRDO) - MarketBeat
Creative Medical Technology Holdings Inc (CELZ) Quarterly 10-Q Report - Quartz
Creative Planning Raises Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Creative Planning Increases Holdings in Universal Health Realty Income Trust (NYSE:UHT) - Defense World
Creative Planning Has $485,000 Stock Position in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) - Defense World
Creative Planning Reduces Stock Holdings in ProShares Ultra Technology (NYSEARCA:ROM) - Defense World
Creative Planning Boosts Stock Position in Teladoc Health, Inc. (NYSE:TDOC) - Defense World
SoldierStrong, USC Institute for Creative Technologies Sign License Agreement for Battle Buddy - Yahoo Finance
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):